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ABSTRACT
Background and study aims Data on clinical outcomes of endo-
scopic drainage of debris-free pseudocysts (PDF) versus pseudo-
cysts containing solid debris (PSD) are very limited. The aims of
this study were to compare treatment outcomes between patients
with PDF vs. PSD undergoing endoscopic ultrasound (EUS)-guided
drainage via transmural stents.
Patients and methods Retrospective review of 142 consecutive
patients with pseudocysts who underwent EUS-guided transmural
drainage (TM) from 2008 to 2014 at 15 academic centers in the Uni-
ted States. Main outcome measures included TM technical success,
treatment outcomes (symptomatic and radiologic resolution), need
for endoscopic re-intervention at follow-up, and adverse events
(AEs).
Results TM was performed in 90 patients with PDF and 52 with
PSD. Technical success: PDF 87 (96.7%) vs. PSD 51 (98.1%). There
was no difference in the rates for endoscopic re-intervention (5.5%
in PDF vs. 11.5% in PSD; P=0.33) or AEs (12.2% in PDF vs. 19.2% in
PSD; P=0.33). Median long-term follow-up after stent removal was
297 days (interquartile range [IQR]: 59–424 days) for PDF and 326
days (IQR: 180–448 days) for PSD (P=0.88). There was a higher rate
of short-term radiologic resolution of PDF (45; 66.2%) vs. PSD (21;
51.2%) (OR=0.30; 95% CI: 0.13–0.72; P=0.009). There was no dif-
ference in long-term symptomatic resolution (PDF: 70.4% vs. PSD:
66.7%; P=0.72) or radiologic resolution (PDF: 68.9% vs. PSD:
78.6%; P=0.72)
Conclusions There was no difference in need for endoscopic re-
intervention, AEs or long-term treatment outcomes in patients
with PDF vs. PSD undergoing EUS-guided drainage with transmur-
al stents. Based on these results, the presence of solid debris in
pancreatic fluid collections does not appear to be associated
with a poorer outcome.
Original article
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Introduction
Pancreatic fluid collections (PFCs) can develop as a conse-
quence of pancreatic duct leak/disruption or pancreatic inflam-
mation [1–3]. A pancreatic pseudocyst is a type of PFC en-
closed in a non-epithelialized wall. While pseudocysts develop
in up to 20% of cases of acute pancreatitis and 40% of patients
with chronic pancreatitis, most of them resolve spontaneously
[4]. Treatment is warranted in the setting of symptoms (i. e. ab-
dominal pain, early satiety, weight loss, luminal and/or biliary
obstruction) and/or cyst-associated adverse events (i. e. infec-
tion, bleeding) [5].
Endoscopic transmural (TM) drainage has become first-line
therapy for symptomatic pancreatic pseudocysts given its sim-
ilar efficacy, shorter recovery times, fewer adverse events (AEs)
and improved cost-effectiveness when compared to surgical
cystogastrostomy [6]. This technique involves the creation of a
communication between the pseudocyst and the gastroduode-
nal lumen (cystogastrostomy or cystoduodenostomy), allowing
the internal drainage and collapse of the pseudocyst [7].
Several factors have been associated with the technical and
clinical success of endoscopic drainage. Presence of solid debris
within the cystic cavity has been historically regarded as a neg-
ative factor on endoscopic drainage, in part due to the worse
clinical outcomes in patients with walled-off necrosis (WON)
[8]. The revised Atlanta classification distinguishes different
types of PFCs based on morphologic features seen on contrast-
enhanced computed tomography (CECT) [1]. WON is defined as
a heterogeneous collection with varying amounts of non-liquid
density that has developed from acute necrotizing pancreatitis
whereas a pseudocyst is defined as a well-encapsulated homo-
genous fluid collection with minimal or no solid debris arising
from interstitial edematous pancreatitis. In spite of this catego-
rical distinction, it is not uncommon in clinical practice to en-
counter some degree of solid debris within a pseudocyst at the
time of EUS-guided drainage. However, as opposed to WON,
data on clinical outcomes of TM drainage of pseudocysts con-
taining variable amount of solid debris (PSD) are very limited.
The primary aim of this multicenter, retrospective study was to
compare symptomatic and radiologic resolution rates at follow-
up in patients undergoing EUS-guided drainage of debris-free
pseudocysts (PDF) versus PSD. A secondary aim was to assess
the need for endoscopic re-intervention and adverse events be-
tween the two groups.
Patients and methods
This multicenter retrospective study included all consecutive
patients aged ≥18 years who underwent attempted EUS-guid-
ed pseudocyst drainage at 15 academic tertiary referral centers
in the United States between January 2008 and September
2014. Patients were identified through prospectively main-
tained endoscopic databases and chart review. All data were
extracted and compiled into a central database. Informed pro-
cedural consents were obtained from all patients. This study
was approved by the institutional review board for human re-
search at each of the participating institutions. All endoscopic
procedures were performed according to the ASGE practice
guideline recommendations on antibiotic prophylaxis and man-
agement of antithrombotic agents and coagulopathy [9, 10].
All patients with clinical and/or radiographic evidence of ne-
crotizing pancreatitis and features of WON on index imaging
(based on the revised Atlanta classification) were excluded. All
patients who had any other form of intervention (i. e. percuta-
neous, surgical and/or endoscopic transpapillary drainage)
prior to EUS-guided drainage were also excluded.
Data collection was separated into 3 categories: baseline,
procedural, and post-procedural data. Baseline data of interest
included patient demographics, etiology of pancreatitis, pres-
ence of chronic pancreatitis, pseudocyst characteristics, and
findings on index imaging prior to drainage. Procedure-related
data included technical aspects for TM drainage. Relevant data
included presence or absence of solid debris within the pseudo-
cyst, method of cystoenterostomy tract creation, route of
drainage, type and number of transmural stent(s) used. All pro-
cedure-related AEs were reviewed. Post-procedure data includ-
ed duration of follow-up, need for additional intervention(s),
and treatment outcomes.
Definitions
PFCs were classified as per the revised Atlanta classification as
acute peripancreatic fluid collection (APFC), pseudocysts,
acute necrotic collection (ANC) or walled-off necrosis (WON)
[9]. AEs were assessed based on previously established criteria
by the American Society of Gastrointestinal Endoscopy (ASGE)
[11]. Patients were divided into 2 groups: debris-free pseudo-
cyst (PDF) versus pseudocyst with solid debris (PSD); this defi-
nition was based on the pseudocyst characteristics found on
EUS examination at time of TM drainage. PDF was defined as
absence of any debris within a pseudocyst, whereas PSD was
defined as a pseudocyst containing variable amounts of solid
material (▶Fig. 1). TM technical success was defined as suc-
cessful placement of a minimum of one transmural stent during
pseudocyst drainage. Symptom resolution was defined as the
complete absence of any symptoms, including pain, gastric
outlet obstruction, biliary obstruction, and/or infection. Radi-
ologic resolution was defined as the complete resolution of
the pseudocyst on repeat imaging at the time of follow-up.
Main outcome measures
The primary aim of the study was to compare symptomatic and
radiologic resolution of patients with PDF vs. PSD who under-
went EUS-guided TM drainage. A secondary aim was to com-
pare rates of endoscopic re-intervention and adverse events
between the two groups.
Follow-up
Clinical and radiologic follow-up was performed at the discre-
tion of the endoscopist and care team at each participating in-
stitution. Treatment outcome measures were evaluated at both
short-term and long-term follow-up. In clinical practice, most
TM stents are usually kept in place for a period of 3 weeks to 5
weeks, at which time repeat evaluation (i. e. clinic visit, ima-
ging) is performed in order to assess interval changes and help
dictate timing of stent removal. We defined short-term follow-
Yang Dennis et al. Clinical outcomes of… Endoscopy International Open 2017; 05: EE130–EE136 E131
Th
is
 d
oc
um
en
t w
as
 d
ow
nl
oa
de
d 
fo
r p
er
so
na
l u
se
 o
nl
y.
 U
na
ut
ho
riz
ed
 d
ist
rib
ut
io
n 
is 
st
ric
tly
 p
ro
hi
bi
te
d.
up as an interval ≥2 weeks following transmural stent place-
ment but prior to stent removal in order to assess treatment ef-
ficacy at the time of patient reevaluation. Long-term follow-up
was defined as a period ≥2 weeks following transmural stent re-
moval. The main objective of using this definition was to evalu-
ate clinical outcomes once the stent had been removed and not
prior to this event.
Statistical analysis
Descriptive statistics were calculated for all demographic, ima-
ging, and clinical variables and were reported as mean ± stand-
ard deviation (SD), median with interquartile ranges (IQR), and/
or as a proportion. Univariate analysis was performed by using
the chi-square test and the Fisher’s exact test for categorical
variables and Mann-Whitney test for continuous variables
when indicated. All statistical analysis was performed with the
SPSS software v22 (IBM, SPSS Statistics, Armonk, NY). A P value
less than 0.05 was considered statistically significant.
Results
Patient characteristics and pancreatic pseudocysts
Two hundred and fifteen patients underwent EUS-guided TM
drainage during the study period. A total of 142 patients were
diagnosed with pseudocysts based on the revised Atlanta clas-
sification [9]. Of these patients, there were 90 patients with
PDF and 52 with PSD based on EUS imaging characteristics at
the time of TM drainage.
Baseline characteristics of patients with pseudocysts who
underwent TM drainage are summarized in ▶Table1. There
was no significant differences in patient age, sex, etiology of
acute pancreatitis, presence of chronic pancreatitis or pseudo-
cyst location in patients with PDF vs. PSD. The median size of
the pseudocysts was similar in both groups: PDF (9.0 cm; IQR:
7.4–12.2 cm) and PSD (9.0 cm; IQR: 7.5–13.3 cm) (P=0.92).
Overall, abdominal pain was the most common indication for
pseudocyst drainage in both groups (90% in PDF vs. 92.3% in
PSD; P=0.77). Other indications included gastric outlet ob-
struction, biliary obstruction, and/or infection (▶Table 1).
Technical parameters and outcomes
EUS-guided transmural drainage
The procedural technique of EUS-guided drainage for patients
with PDF vs. PSD is summarized in ▶Table2. In both groups, a
19-gauge EUS needle was used for access and fistula creation
via a transgastric or transduodenal approach in most cases.
There was no significant difference in the type of transmural
stent(s) used for pseudocyst drainage between the two groups.
The most common TM drainage intervention was placement of
a median of 2 10 Fr double-pigtail plastic stents (53.3% in PDF
vs. 57.7% in PSD; P=0.73) or 2 7 Fr double-pigtail plastic stents
(38.9% in PDF vs. 30.8% in PSD; p=0.37). In all cases where a
metal stent was placed for TM drainage (▶Table2), a 7 Fr or
10 Fr plastic double pigtail stent was placed through the lumen
for anchorage and to assist with drainage. Overall, stent(s) re-
mained in place for a median of 97 and 95 days in the PDF and
PSD groups, respectively (P =0.25).
Technical success and need for endoscopic re-intervention
Technical success rate for TM drainage was 96.7% (87/90) in
PDF and 98.1% (51/52) in PSD (P =0.63). Reasons for failure in
the 3 patients from the PDF group included inability to dilate
the fistulous tract in 1, hypoxemia with termination of the pro-
cedure in 1, and failure to advance the stent in 1 patient. TM
drainage was unsuccessful in 1 patient with PSD due to stent
migration following deployment resulting in perforation. The
migrated stent was removed followed by endoscopic closure
of the gastric defect.
There was no difference in the need for endoscopic re-inter-
vention (within 4 weeks from time of TM drainage) between
patients with PDF (5/90; 5.5%) vs. PSD (6/52; 11.5%) (OR
2.22; 95% CI: 0.64–7.66; P =0.33). Endoscopic re-intervention
consisted of stent replacement and/or upsizing. Infection was
the most common indication for re-intervention for PDF (2/90;
2.2%) and PSD (4/52; 7.7%) (OR 0.27; 95% CI: 0.05–1.5; P =
0.19). Persistent or enlarging symptomatic pseudocyst was an
indication for re-intervention in 1 patient with PDF and in 2 pa-
tients with PSD (OR 0.28; 95% CI: 0.02–3.18; P=0.55). Endo-
scopic re-intervention was performed for stent migration in 2
patients with PDF but none with PSD (P=0.53). There were no
cases of stent occlusion requiring revision in either group.
Procedural adverse events
Overall, AE rates were not significantly different between pa-
tients with PDF (12.2%) vs. PSD (19.2%) (P=0.33). Procedural
AEs for pseudocyst drainage are summarized in ▶Table 3.
Bleeding was managed with endoscopic hemostasis and blood
transfusion (n=4) or coil embolization by interventional radiol-
ogy (n =4). Three cases of perforation during TM stent place-
▶ Fig. 1 a Endosonographic and endoscopic view of EUS-guided
transmural drainage of a debris-free pseudocyst. b Endosono-
graphic and endoscopic view of EUS-guided transmural drainage of
a pseudocyst containing solid debris.
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ment did not require any specific intervention whereas endo-
scopic removal of a migrated stent and gastric defect closure
was performed in one patient with PSD. Infection was reported
in 6 patients (2 with PDF and 4 with PSD; P =0.19). All of these
patients were managed with antibiotic therapy and repeat
endoscopic drainage with upsizing of TM stent(s). In addition
to antibiotics and stent upsizing, 4 of these 6 patients also had
additional interventions: 2 patients (1 with PDF and 1 with PSD)
had concomitant insertion of a nasocystic drain and 2 patients
(both with PSD) underwent computed tomography-guided
▶Table 1 Patient characteristics of patients with pseudocysts undergoing endoscopic drainage.
Baseline characteristics PDF (n=90) PSD (n=52) P value
Age, mean (SD), years 53 (16.1) 51.9 (16.8) 0.54
Males; n(%) 61 (67.8) 32 (61.5) 0.47
Etiology of acute pancreatitis, n(%)
ETOH
Gallstones
Idiopathic
Other
27 (30)
21 (23.3)
23 (25.6)
19 (21.1)
17 (32.7)
16 (30.8)
10 (19.2)
 9 (17.3)
0.85
0.43
0.42
0.67
Presence of underlying chronic pancreatitis, n (%) 22 (24.4) 13 (25) 1.00
Size of drained pseudocyst, median (interquartile range), cm  9 (7.4–12.2)  9 (7.5–13.3) 0.92
Pseudocyst location; n(%)
Head
Body
Tail
22 (24.4)
52 (57.8)
30 (33.3)
13 (25)
35 (67.3)
20 (38.5)
1.00
0.29
0.59
Indication for drainage, n(%)
Pain
Gastric outlet obstruction
Biliary obstruction
Infection
81 (90)
19 (21.1)
 4 (4.4)
 8 (8.9)
48 (92.3)
 7 (13.5)
 1 (1.9)
 6 (11.5)
0.77
0.37
0.65
0.77
▶Table 2 Transmural drainage technique.
Transmural drainage technique PDF (n=90) PSD (n=52) OR (95% CI) P value
Access route; n(%)
Trans-gastric
Trans-duodenal
Unspecified
79 (87.8)
 5 (5.6)
 6 (6.7)
45 (86.5)
 5 (9.6)
 2 (3.8)
1.12 (0.40–3.09)
0.55 (0.15–2.01)
1.79 (0.35–9.19)
1.00
0.50
0.71
Type of transmural stent placed, n(%)
Plastic
Metal
Lumen-apposing transmural stent
Unspecified
72 (80)
10 (11.1)
 2 (2.2)
 6 (6.7)
37 (71.2)
12 (23.1)
 3 (5.8)
 0
1.62 (0.73–3.58)
0.42 (0.17–1.05)
0.37 (0.06–2.30)
–
0.30
0.09
0.36
0.08
Endoscopic re-intervention within 4 weeks  5 (5.5)  6 (11.5) 0.45 (0.13–1.56) 0.33
▶Table 3 Adverse events.
Adverse event PDF (n =90) PSD (n=52) OR (95% CI) P value
Bleeding  4 (4.4)  4 (7.7) 0.79 (0.43 –7.49) 0.46
Perforation  2 (2.2)  2 (3.8) 1.76 (0.24 –12.88) 0.62
Infection  2 (2.2)  4 (7.7) 0.27 (0.05 –1.5) 0.19
Cardiopulmonary  1 (1.1)  0 – 1.00
Death  1 (1.1)  0 – 1.00
Other  1 (1.1)  0 – 1.00
Overall 11/90 (12.2) 10/52 (19.2) 0.58 (0.23 –1.49) 0.33
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percutaneous drain placement. These adjunct interventions
were performed given concern that the infected pseudocyst
would not be adequately drained by TM stent upsizing alone.
One patient with PDF died from cardiopulmonary arrest follow-
ing aspiration.
Treatment outcomes and follow-up
The median short-term follow-up was the same for patients
with PDF (50 days; IQR: 35–86 days) vs. PSD (50 days; IQR:
37–75 days) (P=0.87). Complete symptomatic resolution at
short-term follow-up was reported in 39 (70.9%) patients with
PDF and 25 (58.1%) patients with PSD (Odds ratio [OR] =1.56;
95% CI: 0.66–3.67; P =0.38) (▶Fig. 2). Radiologic resolution
of PFC was significantly higher in PDF group (45 /68; 66.2%)
compared to the PSD group (21/41; 51.2%) (OR=0.30; 95%
CI: 0.13–0.72; P =0.009) (▶Fig. 2). There was no difference in
symptomatic or radiologic resolution rates in neither group
(PDF or PSD) between patients who had TM drainage with met-
al versus plastic stents (data not shown).
The median long-term follow-up was 297 (IQR: 59–424)
days for patients with PDF and 326 (IQR: 180–448) days for
PSD (P=0.88). At long-term follow-up, there was no significant
difference in symptomatic resolution (70.4% in PDF vs 66.7% in
PSD) (OR=0.84; 95% CI: 0.22–3.26; P=1.00) or radiologic re-
solution of pseudocyst (68.9% in PDF vs 78.6% in PSD) (OR=
1.65; 95% CI: 0.37–7.39; P=0.72) between the 3 cohorts
(▶Fig. 2). In aggregate, 33 (23.2%) and 98 (69%) patients
were lost to short- and long-term follow-up, respectively.
Discussion
Endoscopic TM drainage has largely replaced surgery as first-
line therapy for management of pancreatic pseudocysts due
its comparable clinical efficacy, shorter post-procedural recov-
ery time, lower costs, and AE rates [6]. While EUS-guided drain-
age has been recognized as the standard of care for manage-
ment of symptomatic PFCs [12, 13], the optimal endoscopic ap-
proach for each type of PFC has not been well defined, particu-
larly in patients with pseudocysts who are subsequently noted
to have varying degrees of non-liquid component at the time of
the endoscopic procedure (but not seen at time of CECT). In
this large multicenter study, there was no difference in long-
term treatment outcomes, need for endoscopic re-interven-
tion, or AE rates in patients with debris-free pseudocysts (PDF)
versus those with pseudocysts containing solid-debris (PSD)
undergoing EUS-guided drainage via transmural stents only.
The Revised Atlanta classification [1] distinguishes types of
PFCs based on features on cross-sectional imaging, including
whether there is an encapsulating wall and the presence of so-
lid components within the collection. While most pseudocysts
are characterized by a well-defined inflammatory capsule with
minimal or no solid material, it is not uncommon in clinical
practice to identify varying amounts of layering internal debris
within the pseudocyst at the time of endoscopic drainage. In
cases where viscous fluid and/or layering debris within a pseu-
docyst may potentially hinder endoscopic drainage, the use of a
nasocystic drain in addition to endoprosthesis has been pre-
viously proposed. In a prospective study of 40 patients, Puri et
al demonstrated that pancreatic pseudocyst drainage with
both endoprosthesis and nasocystic tube placement was safe
and associated with high success rate (32/40; 80%) [14]. More
recently, Siddiqui et al compared outcomes of EUS-guided ther-
apy of PSD by using combined endoprosthesis and a nasocystic
drain (n=63) versus transmural stents only (n=24) [15]. Over-
all, technical success was achieved in 87/88 (99%) and proce-
dure-related AEs occurred in 9/87 (10.3%) of the patients. At
1-month follow-up, relief of symptoms and at least 30% de-
crease in pseudocyst size was achieved in 85% of PSD drained
via the combined approach versus 63% of those treated via
stents alone (OR 3.6; 95% CI: 1.2–10.7; P=0.03). At a median
follow-up of 16 months (range 13–27 months), there was not a
significant difference in treatment success rate between pa-
tients who had combined drainage (79%) versus stent alone
(58%) (P=0.06). Overall, the authors concluded that short-
term clinical outcomes in patients with PSD are improved by
combined nasocystic drain and endoprosthesis drainage.
There are several potential limitations of adopting a routine
combined endoprosthesis and nasocystic drain approach for
the management of PSD as suggested by Siddiqui and collea-
gues. First, all patients in their study were admitted to the hos-
pital after the procedure and pseudocyst lavage via the naso-
cystic tube was performed with normal saline solution with
100ml/hour for 48 to 72 hours. Besides the clear risks associat-
ed with potential nosocomial exposure during routine post-
procedural hospital admission, this clinical practice can signifi-
cantly increase costs and length of stay associated with the pro-
cedure; and thereby, potentially obviates some of the estab-
lished advantages of endoscopic drainage over a surgical ap-
proach. Aggressive irrigation of the cystic cavity requires close
monitoring and ancillary staff resources to minimize the risk of
EUS-guided TM technical success: 
PDF 87/90 (97 %) vs. PSD 51/52 (98 %) (P = 1.00)
PDF (n = 90)
Symptomatic 
resolution
39/55 (71 %)
Radiologic* 
resolution
45/68 (66 %)
Symptomatic 
resolution
25/41 (58 %)
Radiologic* 
resolution
21/41 (51 %)
Median short-term follow-up
 50 (35 – 86) days 50 (37 – 75) days
Symptomatic 
resolution
19/27 (70 %)
Radiologic 
resolution
20/29 (69 %)
Symptomatic 
resolution
10/15 (67 %)
Radiologic 
resolution
11/14 (79 %)
Median long-term follow-up
 297 (59 – 424) days 326 (180 – 448) days
PSD (n = 52)
▶ Fig. 2 Treatment outcomes (symptomatic and radiologic reso-
lution) and follow-up.
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serious adverse events such as aspiration. Last but not least,
many patients may not tolerate an indwelling nasocystic tube
for such an extended period of time. As such, it is difficult to
advocate for routine use of combined endoprosthesis and naso-
cystic drain placement in all patients with PSD, especially in the
absence of conclusive literature supporting its use in this set-
ting.
In this multicenter study, we demonstrate similar long-term
outcomes in patients with PDF versus PSD undergoing EUS-
guided endoscopic drainage via transmural stents only. Our
technical success rate of TM drainage was high and not signifi-
cantly different for PDF (96.7%) versus PSD (98.1%) (P=0.63).
This high technical success rate is comparable and in agree-
ment to those previously reported, alluding to the external va-
lidity of our findings [6–8, 13]. Similar to the prior study by Sid-
diqui et al, our results suggest higher rate of complete radiolo-
gic resolution at short-term follow-up in patients with PDF
(66.2%) compared to PSD (51.2%) (OR 0.30; 95% CI: 0.13–
0.72; P=0.009). This would intuitively make sense as a cyst cav-
ity containing layering debris would require more time for its
components to completely liquefy and drain when compared
to a pseudocyst without any debris. In spite of this radiographic
difference, short-term symptomatic resolution rates were
similar between both groups and there was also no difference
in the need for endoscopic re-intervention (5.5% in PDF vs.
11.5% in PSD; P=0.33) at follow-up.Overall, these findings sug-
gest that while short-term radiologic resolution of pseudocyst
may be slower for those with PSD vs. PDF, there was no differ-
ence in other surrogate markers (i. e. symptomatic resolution
and need for re-intervention) of clinical improvement between
the 2 groups. Even more importantly, the results from this
study did not demonstrate any statistically significant differen-
ces in long-term clinical outcomes or rate of AEs in patients
with PDF or PSD undergoing EUS-guided TM drainage.
This study has several strengths. This is the largest and only
multicenter experience comparing outcomes in patients with
PDF versus PSD undergoing EUS-guided drainage with trans-
mural stents only. Second, all patients with pseudocysts were
identified based on established criteria and by the omission of
patients with evidence of necrotizing pancreatitis or obvious
WON on index cross-sectional imaging in an effort to avoid
PFC misclassification [1, 16]. Third, instead of using post-drain-
age PFC size as the only surrogate marker for treatment suc-
cess, the main outcomes in this study were defined as complete
resolution of symptoms and radiographic findings on follow-up
and the need for endoscopic re-intervention, presumably clini-
cally more relevant endpoints. Lastly, not only was treatment
efficacy assessed immediately following endoscopic drainage,
but long-term treatment effect was estimated by evaluating
clinical outcomes after transmural stent removal. This is a key
point as ultimate therapeutic outcomes should be assessed
once the prostheses are removed, thus signaling the true com-
pletion of therapy. T
There are also limitations to this study. The study design was
retrospective with its inherent limitations. As such, presence of
solid debris within a pseudocyst was qualitatively determined
by the endoscopist at the time of the EUS but a standardized
quantitative assessment was not available across all participat-
ing institutions. This potentially increases the heterogeneity
within the PSD group and underscores the need for future pro-
spective comparative trials. Second, in aggregate, rates of
symptom and radiologic resolution (68.9%–78.6%) of pseudo-
cysts following endoscopic drainage in this study appear to be
lower than those reported in the literature, which range from
75% to 100% [6–8, 13, 14]. This discrepancy in outcomes can
be in part accounted for by the heterogeneous criteria used in
defining treatment success, varied procedural techniques em-
ployed, diverse patient populations and timing of the interven-
tions among the prior studies, as well as our own use of very
stringent criteria for ST and LT follow-up and definitions of suc-
cess. Another major limitation is that a significant portion of
patients were lost to follow-up and thus the potential for selec-
tion bias. Most of the participating institutions in this study are
tertiary referral centers and thus a large proportion of patients
included in this study were lost to follow-up upon completion
of the intervention. We acknowledge that the loss to LT follow-
up limits the interpretability of our current findings and conclu-
sions. Consequently, due to the relative small sample size, the
study could have been underpowered to detect statistically sig-
nificant differences between the 2 groups. Lastly, while this
study represents the largest multicenter series evaluating out-
comes associated with EUS-guided drainage of PSD, small sam-
ple size on subgroup analysis could have precluded detection of
any meaningful differences in outcomes. Hence, the lack of sta-
tistically significant difference may not necessarily exclude the
possibility of clinically relevant differences.
Conclusion
In summary, this study demonstrated similar treatment out-
comes in patients with PDF versus PSD undergoing EUS-guided
drainage via placement of transmural stents only. Drainage was
successful in most of the patients with placement of transmural
plastic stents, which suggests that this may still be an effica-
cious and cost-effective alternative to use of fully-covered lu-
men-apposing stents. While short-term radiologic resolution
of pseudocyst was higher in PDF versus PSD, there were no dif-
ferences in need for endoscopic re-intervention or long-term
symptomatic or radiologic outcomes between the 2 groups. Fu-
ture larger comparative prospective studies are needed to eval-
uate whether transmural stenting alone and the type of stent
for that matter, is sufficient for adequate drainage of patients
with PSD.
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